Sign up to save your podcasts
Or
Share The Drug Development Landscape: Trends and Predictions for 2024
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Drug Development Landscape: Trends and Predictions for 2024
We are kickstarting 2024 with a Conversation in Drug Development with CEO and Founder of Boyds, Professor Alan Boyd. In this podcast episode, our host Harriet Edwards, and Professor Alan Boyd discuss trends from 2023 in the drug development space and its potential evolution in 2024. Join us as we explore the financial downturn affecting early-stage investment, the rise of cell and gene therapy approvals, and the use of artificial intelligence in various areas of drug discovery and development.
View all episodes
By Boyds
5
33 ratings
We are kickstarting 2024 with a Conversation in Drug Development with CEO and Founder of Boyds, Professor Alan Boyd. In this podcast episode, our host Harriet Edwards, and Professor Alan Boyd discuss trends from 2023 in the drug development space and its potential evolution in 2024. Join us as we explore the financial downturn affecting early-stage investment, the rise of cell and gene therapy approvals, and the use of artificial intelligence in various areas of drug discovery and development.
More shows like Conversations in Drug Development
View all
Economist Podcasts
4,278 Listeners
Freakonomics Radio
32,283 Listeners
Two Scientists Walk Into a Bar
309 Listeners
Up First from NPR
56,221 Listeners
JAMA Medical News
90 Listeners
The Long Run with Luke Timmerman
122 Listeners
The Readout Loud
318 Listeners
The Journal.
5,942 Listeners
SCRS Talks
0 Listeners
Business Of Biotech
88 Listeners
Pharma Market Access Insights - from Petauri Evidence
2 Listeners
Raising Health
147 Listeners
From Lab to Launch by Qualio
8 Listeners
Transformation in Trials
0 Listeners
Business Of Biotech
88 Listeners